Resnicoff M, Tjuvajev J, Rotman H L, Abraham D, Curtis M, Aiken R, Baserga R
Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA.
J Exp Ther Oncol. 1996 Nov;1(6):385-9.
We have previously shown that C6 cells expressing an antisense insulin-like growth factor I receptor (IGF-IR) RNA are no longer tumorigenic in syngeneic rats, protecting them from subsequent subcutaneous tumor challenge and causing regression of established subcutaneous tumors. In the present study, we have investigated the efficacy of this strategy on intracerebrally implanted C6 rat glioblastoma cells. We demonstrate that C6 cells expressing an antisense IGF-IR RNA implanted for 24 h in the subcutaneous tissue of the rats are able to elicit an anti-tumor response in the brain, leading to complete brain tumor regression and long-term survival of the rats. These findings suggest the possibility of therapeutic intervention in human gliomas.
我们先前已表明,表达反义胰岛素样生长因子I受体(IGF-IR)RNA的C6细胞在同基因大鼠中不再具有致瘤性,可保护它们免受随后的皮下肿瘤攻击,并使已形成的皮下肿瘤消退。在本研究中,我们调查了该策略对脑内植入的C6大鼠胶质母细胞瘤细胞的疗效。我们证明,在大鼠皮下组织中植入24小时的表达反义IGF-IR RNA的C6细胞能够在脑中引发抗肿瘤反应,导致脑肿瘤完全消退并使大鼠长期存活。这些发现提示了对人类胶质瘤进行治疗干预的可能性。